ATE417618T1 - Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren - Google Patents
Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahrenInfo
- Publication number
- ATE417618T1 ATE417618T1 AT02773804T AT02773804T ATE417618T1 AT E417618 T1 ATE417618 T1 AT E417618T1 AT 02773804 T AT02773804 T AT 02773804T AT 02773804 T AT02773804 T AT 02773804T AT E417618 T1 ATE417618 T1 AT E417618T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- factor viii
- amino acid
- nucleic acid
- expression level
- Prior art date
Links
- 229960000301 factor viii Drugs 0.000 title abstract 3
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 150000001413 amino acids Chemical group 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 108010054218 Factor VIII Proteins 0.000 abstract 2
- 102000001690 Factor VIII Human genes 0.000 abstract 2
- 201000003542 Factor VIII deficiency Diseases 0.000 abstract 2
- 208000009292 Hemophilia A Diseases 0.000 abstract 2
- 102100026735 Coagulation factor VIII Human genes 0.000 abstract 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32738801P | 2001-10-05 | 2001-10-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE417618T1 true ATE417618T1 (de) | 2009-01-15 |
Family
ID=23276347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02773804T ATE417618T1 (de) | 2001-10-05 | 2002-10-07 | Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7635763B2 (de) |
| EP (1) | EP1572889B1 (de) |
| JP (2) | JP4634036B2 (de) |
| AT (1) | ATE417618T1 (de) |
| AU (1) | AU2002337901B2 (de) |
| CA (1) | CA2461443C (de) |
| DE (1) | DE60230456D1 (de) |
| ES (1) | ES2319745T3 (de) |
| WO (1) | WO2003031598A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7560107B2 (en) | 1996-06-26 | 2009-07-14 | Emory University | Modified factor VIII |
| DE60230456D1 (de) * | 2001-10-05 | 2009-01-29 | Expression Therapeutics Llc | Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren |
| US7485291B2 (en) | 2003-06-03 | 2009-02-03 | Cell Genesys, Inc. | Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| EP1636360A4 (de) | 2003-06-03 | 2006-11-08 | Cell Genesys Inc | Zusammensetzungen und verfahren zur verstärkten expression rekombinanter polypeptide von einem vektor unter verwendung einer peptidspaltstelle |
| PT1750733E (pt) * | 2004-05-03 | 2014-02-14 | Baxter Healthcare Sa | Método de administração de factor viii suíno sem domínio b |
| PT2363414T (pt) | 2004-11-12 | 2022-08-04 | Bayer Healthcare Llc | Modificação de fviii direcionada a sítio |
| WO2009140598A1 (en) * | 2008-05-16 | 2009-11-19 | Bayer Healthcare Llc | Targeted coagulation factors and method of using the same |
| MX351220B (es) * | 2010-11-05 | 2017-10-05 | Baxalta GmbH | Una variante nueva del factor viii antihemofilico que tiene actividad especifica incrementada. |
| ES2913994T3 (es) | 2011-07-08 | 2022-06-07 | Bioverativ Therapeutics Inc | Polipéptidos quiméricos e híbridos del Factor VIII, y métodos de uso de los mismos |
| WO2014008172A2 (en) * | 2012-07-03 | 2014-01-09 | Expression Therapeutics, Llc | High yield suspension cell line, system and method for making same |
| US20160102133A1 (en) | 2013-06-24 | 2016-04-14 | Weidong Xiao | Mutant factor viii compositions and methods |
| US10058624B2 (en) | 2015-04-16 | 2018-08-28 | Emory University | Recombinant promoters and vectors for protein expression in liver and use thereof |
| SG10202106307UA (en) | 2015-11-13 | 2021-07-29 | Takeda Pharmaceuticals Co | Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia a |
| CN108602876B (zh) | 2015-11-13 | 2022-07-05 | 武田药品工业株式会社 | 用于血友病a的基因治疗的具有增加的表达的编码重组fviii变体的病毒载体 |
| EP3452102B9 (de) | 2016-04-15 | 2024-09-04 | The Trustees of The University of Pennsylvania | Gentherapie zur behandlung von hämophilie a |
| WO2019040743A1 (en) | 2017-08-23 | 2019-02-28 | Wake Forest University Health Sciences | POST-NATAL TRANSPLANTATION OF CELLS EXPRESSING FACTOR VIII FOR THE TREATMENT OF HEMOPHILIA |
| WO2019040747A1 (en) | 2017-08-23 | 2019-02-28 | Wake Forest University Health Sciences | IN UTERO TRANSPLANTATION OF CELLS EXPRESSING FACTOR VIII FOR THE TREATMENT OF HEMOPHILIA |
| KR20210034013A (ko) | 2018-07-16 | 2021-03-29 | 박스알타 인코퍼레이티드 | 발현이 증가된 재조합 fviii 변이체들을 인코딩하는 바이러스 벡터를 이용한 혈우병의 유전적 치료법 |
| TWI851647B (zh) | 2019-01-16 | 2024-08-11 | 日商武田藥品工業股份有限公司 | 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體 |
| US11680109B2 (en) | 2019-05-29 | 2023-06-20 | Duke University | Compositions and methods for detection and measurement of RNA modifications through targeted RNA editing |
| EP4284412A4 (de) * | 2021-01-29 | 2025-04-09 | Expression Therapeutics, LLC | Nukleinsäure- und aminosäuresequenzen zur codierung von high-level-expressor-faktor-viii-polypeptiden und verfahren zur verwendung |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6376463B1 (en) * | 1992-04-07 | 2002-04-23 | Emory University | Modified factor VIII |
| US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
| US5364771A (en) * | 1992-04-07 | 1994-11-15 | Emory University | Hybrid human/porcine factor VIII |
| US5663060A (en) * | 1992-04-07 | 1997-09-02 | Emory University | Hybrid human/animal factor VIII |
| US5888974A (en) * | 1992-04-07 | 1999-03-30 | Emory University | Hybrid human/animal factor VIII |
| US5744446A (en) * | 1992-04-07 | 1998-04-28 | Emory University | Hybrid human/animal factor VIII |
| US6180371B1 (en) * | 1996-06-26 | 2001-01-30 | Emory University | Modified factor VIII |
| JPH08511423A (ja) * | 1993-06-10 | 1996-12-03 | ジェネティック セラピー，インコーポレイテッド | 血友病治療のためのアデノウイルスベクター |
| US6818439B1 (en) * | 1994-12-30 | 2004-11-16 | Chiron Corporation | Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia and other disorders |
| US6458563B1 (en) * | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
| WO1999029848A1 (en) * | 1997-12-05 | 1999-06-17 | The Immune Response Corporation | Novel vectors and genes exhibiting increased expression |
| US6200560B1 (en) * | 1998-10-20 | 2001-03-13 | Avigen, Inc. | Adeno-associated virus vectors for expression of factor VIII by target cells |
| DE60230456D1 (de) * | 2001-10-05 | 2009-01-29 | Expression Therapeutics Llc | Faktor-viii-polypeptide auf hohem expressionsnivea und verwendungsverfahren |
-
2002
- 2002-10-07 DE DE60230456T patent/DE60230456D1/de not_active Expired - Lifetime
- 2002-10-07 WO PCT/US2002/033403 patent/WO2003031598A2/en active Search and Examination
- 2002-10-07 ES ES02773804T patent/ES2319745T3/es not_active Expired - Lifetime
- 2002-10-07 AT AT02773804T patent/ATE417618T1/de not_active IP Right Cessation
- 2002-10-07 EP EP02773804A patent/EP1572889B1/de not_active Expired - Lifetime
- 2002-10-07 AU AU2002337901A patent/AU2002337901B2/en not_active Ceased
- 2002-10-07 CA CA2461443A patent/CA2461443C/en not_active Expired - Lifetime
- 2002-10-07 JP JP2003534569A patent/JP4634036B2/ja not_active Expired - Lifetime
-
2004
- 2004-03-30 US US10/813,507 patent/US7635763B2/en active Active
-
2009
- 2009-12-11 US US12/636,424 patent/US8188246B2/en not_active Expired - Lifetime
-
2010
- 2010-09-17 JP JP2010210204A patent/JP5162635B2/ja not_active Expired - Lifetime
-
2012
- 2012-05-27 US US13/481,840 patent/US8519111B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2461443C (en) | 2011-07-12 |
| US8188246B2 (en) | 2012-05-29 |
| US20120270266A1 (en) | 2012-10-25 |
| US20050118684A1 (en) | 2005-06-02 |
| JP5162635B2 (ja) | 2013-03-13 |
| WO2003031598A3 (en) | 2006-01-05 |
| JP4634036B2 (ja) | 2011-02-16 |
| AU2002337901B2 (en) | 2008-01-17 |
| US7635763B2 (en) | 2009-12-22 |
| CA2461443A1 (en) | 2003-04-17 |
| JP2011015698A (ja) | 2011-01-27 |
| EP1572889A4 (de) | 2006-09-06 |
| WO2003031598A2 (en) | 2003-04-17 |
| HK1080517A1 (en) | 2006-04-28 |
| US8519111B2 (en) | 2013-08-27 |
| DE60230456D1 (de) | 2009-01-29 |
| US20110077203A1 (en) | 2011-03-31 |
| JP2005518783A (ja) | 2005-06-30 |
| EP1572889B1 (de) | 2008-12-17 |
| EP1572889A2 (de) | 2005-09-14 |
| ES2319745T3 (es) | 2009-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE417618T1 (de) | Faktor-viii-polypeptide auf hohem expressionsniveau codierende nukleinsäure- und aminosäuresequenzen und verwendungsverfahren | |
| YU9404A (sh) | Multimerna, usmerena kontrastna sredstva na bazi peptida | |
| BR0012759A (pt) | Neurotoxinas recombinantes ativáveis | |
| DE60141546D1 (de) | Polypeptide enthaltend extrazellulären Domäne von IL-20RA und/oderr IL-20RB | |
| MXPA03010103A (es) | Peptidos y composiciones anti-microbianos. | |
| NO20100324L (no) | Fremgangsmate for trinnvis festing av polyetylenglykol (PEG) andeler i serie til et polypeptid | |
| DK2014678T3 (da) | KDR-peptider og vacciner indeholdende disse | |
| YU68002A (sh) | Modifikovani faktor viii | |
| ATE386538T1 (de) | Kombinierte verwendung von faktor vii polypeptiden und faktor viii polypeptiden | |
| DE60235761D1 (de) | Isoform des vegfs | |
| ATE368688T1 (de) | Peptide, deren herstellung und verwendung zur bindung von immunglobulinen | |
| NO20073914L (no) | Biologisk aktive peptider | |
| ATE543833T1 (de) | Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen | |
| DE60226321D1 (de) | Zusammensetzungen für die systemische verabreichung von sequenzen, die für knochenmorphogenese-proteinen kodieren | |
| ATE474916T1 (de) | Protease, für die protease codierende dna und verfahren zur herstellung der protease | |
| DE50013400D1 (de) | Dna-sequenz und rekombinante herstellung eines graminaen-allergens | |
| DE60120187D1 (de) | Verkürztes bard1 protein und dessen diagnostische und therapeutische anwendungen | |
| ATE412753T1 (de) | Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür | |
| SE0101519D0 (sv) | Nucleic ACID | |
| DK2186898T3 (da) | Blomstrings-induktion | |
| ATE400288T1 (de) | Peptide mit hohem cysteingehalt | |
| CY1117092T1 (el) | Μοτιβα της οικογενειας παγκρεατικων πολυπεπτιδιων, πολυπεπτιδια και μεθοδοι που τα περιλαμβανουν |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |